The sur­faces of cells are stud­ded with pro­teins used to com­mu­ni­cate with neigh­bors and vis­i­tors. A new method for ...
Barinthus Bio is shifting its focus to just two investigational candidates and cutting about 25% of its workforce in order to extend cash runway into the second quarter of 2026, the company announced ...
Gilead CEO Daniel O’Day says the company will likely look for more deals like its $4.3 billion purchase of CymaBay ...
Pfizer’s Duchenne muscular dystrophy gene therapy failed to meet the primary and key secondary endpoints in a Phase 3 study, ...
Companies still aren't rushing to pay for their workers' GLP-1 weight loss drugs, despite skyrocketing demand and mounting ...
The majority of states have signed onto an amicus brief asking the US Supreme Court to decide whether they have the right to ...
Pfizer is opening up another road to the obesity market, announcing a partnership with one of Flagship Pioneering's startups ...
Senate HELP Committee chair Bernie Sanders (I-VT) is moving to subpoena Doug Langa, Novo Nordisk's EVP of North America ...
Alzheimer's drug manufacturers are asking the FDA to give them more clarity on the different stages of the disease in comments they've submitted on the agency's draft guidance for developing drugs for ...
A bipartisan bill that would essentially ban US biotech companies from using certain Chinese suppliers failed to muster the ...
Avidity Biosciences' antibody oligonucleotide conjugate has shown signs of efficacy in an early-stage test in patients with a ...
Agilent Technologies, a life science CDMO and laboratory product developer, is laying off 184 staffers across six locations ...